IBZM SPECT (Neurodegeneration)

123I-IBZM can be used for differential diagnosis of idiopathic Parkinson's disease and atypical Parkinson's syndromes.

Furthermore, 123I-IBZM is useful for the diagnosis of neuroleptica-induced Parkinson’s disease. An already performed Datscan is an important prerequisite for an examination with 123I-IBZM. Before an examination with 123I-IBZM, various medications must be paused, sometimes for a longer period of time. You will receive detailed information about this after registering for the examination with 123I-IBZM.

Indications

Responsible doctors

Martin Hüllner, Prof. Dr. med.

Senior Attending Physician, Vice Director of Department, Department of Nuclear Medicine

Tel. +41 44 255 25 80
Specialties: Research group: Hybrid and molecular tumor imaging, PET/CT and PET/MR, SPECT/CT

Lars Husmann, Prof. Dr. med.

Attending Physician, Department of Nuclear Medicine

Tel. +41 43 253 87 99

Cäcilia Mader, Dr. med.

Attending Physician with extended responsibilites, Department of Nuclear Medicine

Tel. +41 43 253 88 02

Alexander Maurer, Dr. med.

Attending Physician with extended responsibilites, Department of Nuclear Medicine

Tel. +41 43 253 88 09
Specialties: Multimodal oncological hybrid imaging (PET/CT and PET/MRI), Imaging of prostate cancer (PSMA PET), SPECT/CT

Michael Messerli, PD Dr. med.

Attending Physician with extended responsibilites, Department of Nuclear Medicine

Tel. +41 43 253 88 03
Specialties: Multimodal oncological imaging, Thoracic imaging, Research group: Hybrid and molecular tumor imaging

For patients

As a patient, you cannot register directly for a consultation. Please have your family doctor, specialist refer you. If you have any questions, please use our contact form.

Tel. +41 44 255 35 55
Contact formular

For referring physicians

Simply assign your patient via registration form.

Tel. +41 44 255 35 55

Medical information hotline: 08.00-18.00 o’clock: +41 44 255 15 02

Registration form

Responsible Department